| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052749 | The Journal of Urology | 2005 | 4 Pages |
Abstract
p53 is a significant molecular predictor of tumor recurrence, as identified in patients undergoing treatment for localized RCC.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
OLEG SHVARTS, DAVID SELIGSON, JOHN LAM, TAO SHI, STEVE HORVATH, ROBERT FIGLIN, ARIE BELLDEGRUN, ALLAN J. PANTUCK,